Skip to main content
SpringerLink
Log in

Pharmacist’s Role and Pharmaceutical Care During the COVID-19 Pandemic

  • Chapter
  • First Online:
Coronavirus Disease - COVID-19

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1318))

Abstract

Pharmacists play a vital role in public health during the COVID-19 pandemic. In this chapter, we present the most significant contributions that pharmacists could make to communitarian and hospital settings. It includes the provision of essential services, such as continuous access to medication and supplies, support to medical services, education and information to the population and the health team to reduce the misuse of medications, patient monitoring and follow-up, and the detection and referral of suspected cases of COVID-19. The chapter ends with a discussion over certain elements related to innovation needs, such as telepharmacy services.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Adams KK, Baker WL, Sobieraj DM (2020) Myth busters: dietary supplements and COVID-19. Ann Pharmacother:106002802092805. https://doi.org/10.1177/1060028020928052

  • Adunlin G, Murphy PZ, Manis M (2020) COVID-19: how can rural community pharmacies respond to the outbreak? J Rural Health. https://doi.org/10.1111/jrh.12439

  • Al-Quteimat OM, Amer AM (2020) SARS-CoV-2 outbreak: how can pharmacists help? Res Soc Adm Pharm:S1551741120302382. https://doi.org/10.1016/j.sapharm.2020.03.018

  • Amariles P, Hincapie-García J, Julio Montoya C (2020a) Pharmacotherapy for hospitalized patients with COVID-19: Waiting or doing? Res Soc Adm Pharm:S1551741120305301. https://doi.org/10.1016/j.sapharm.2020.05.010

  • Amariles P, Ledezma-Morales M, Salazar-Ospina A, Hincapié-García JA (2020b) How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Soc Adm Pharm:S1551741120302485. https://doi.org/10.1016/j.sapharm.2020.03.007

  • American Pharmacists Association (2020) Coronavirus: resources for pharmacists and an interview with a virus expert

    Google Scholar 

  • Aruru M, Truong H-A, Clark S (2020) Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Soc Adm Pharm: S1551741120303235. https://doi.org/10.1016/j.sapharm.2020.04.002

  • Bukhari N, Rasheed H, Nayyer B, Babar Z-U-D (2020) Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy and Pract 13(1):8,-s40545-40020-00210-w. https://doi.org/10.1186/s40545-020-00210-w

    Article  Google Scholar 

  • Cadogan CA, Hughes CM (2020) On the frontline against COVID-19: community pharmacists’ contribution during a public health crisis. Res Soc Adm Pharm:S1551741120302928. https://doi.org/10.1016/j.sapharm.2020.03.015

  • Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/NEJMoa2001282

    Article  PubMed  Google Scholar 

  • Carico RR, Sheppard J, Thomas CB (2020) Community pharmacists and communication in the time of COVID-19: applying the health belief model. Res Soc Adm Pharm:S155174112030293X. https://doi.org/10.1016/j.sapharm.2020.03.017

  • Center for Disease Control and Prevention (2020) Coronavirus disease 2019 (COVID-19) – interim guidance for businesses and employers

    Google Scholar 

  • Chinese Pharmaceutical Association (2020) SARS-CoV-2 infection: expert consensus on guidance and prevention and control strategies for retail pharmacy workforce (1st edition)

    Google Scholar 

  • Consejo General de Colegios Farmacéuticos (2020) Procedimiento de actuación en la farmacia comunitaria en casos de infección por COVID-19

    Google Scholar 

  • Dawoud D (2020) Emerging from the other end: key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Soc Adm Pharm:S1551741120305313. https://doi.org/10.1016/j.sapharm.2020.05.011

  • Erku DA, Belachew SA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, Tesfaye WH (2020) When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Res Soc Adm Pharm:S1551741120304551. https://doi.org/10.1016/j.sapharm.2020.04.032

  • Faus Dáder MJ, Sabater-Hernández D, Amariles P (2007) Types of pharmacist interventions intended to prevent and solve negative outcomes associated with medication. Pharmacotherapy 7:e51–e52

    Google Scholar 

  • Faus Dáder MJ, Amariles P, Martinez-Martinez F (2018) Atención farmacéutica servicios farmacéuticos orientados al paciente. Avicam, Armilla

    Google Scholar 

  • Foro de Atención Farmacéutica-Farmacia C (2019) Guía práctica para los Servicios Profesionales Farmacéuticos Asistenciales en la Farmacia Comunitaria. Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, España

    Google Scholar 

  • Gamble A, Pham Q, Goyal S, Cafazzo JA (2020) The challenges of COVID-19 for people living with diabetes: considerations for digital health. JMIR Diabetes 5(2):e19581. https://doi.org/10.2196/19581

    Article  PubMed  PubMed Central  Google Scholar 

  • Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine 0 (0): null. https://doi.org/10.1056/NEJMoa2012410

  • Gross AE, MacDougall C (2020) Roles of the clinical pharmacist during the COVID-19 pandemic. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF. Clin Pharm 3(3):564–566. https://doi.org/10.1002/jac5.1231

    Article  Google Scholar 

  • Hasan SS, Kow CS, Zaidi STR (2020) Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures? Res Soc Adm Pharm:S1551741120304903. https://doi.org/10.1016/j.sapharm.2020.04.033

  • Hedima EW, Adeyemi MS, Ikunaiye NY (2020) Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm:S1551741120303818. https://doi.org/10.1016/j.sapharm.2020.04.017

  • Hua X, Gu M, Zeng F, Hu H, Zhou T, Zhang Y, Shi C (2020) Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc:S1544319120301539. https://doi.org/10.1016/j.japh.2020.04.006

  • Iacobucci G (2020) Covid-19: allow pharmacists to dispense controlled drugs without prescription, urge specialists. BMJ:m1868. https://doi.org/10.1136/bmj.m1868

  • International Pharmaceutical Federation (2020) COVID-19: Guidelines for pharmacists and the pharmacy workforce

    Google Scholar 

  • Kretchy IA, Asiedu-Danso M, Kretchy J-P (2020) Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Soc Adm Pharm:S1551741120303326. https://doi.org/10.1016/j.sapharm.2020.04.007

  • Li H, Zheng S, Liu F, Liu W, Zhao R (2020) Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Soc Adm Pharm:S1551741120303284. https://doi.org/10.1016/j.sapharm.2020.04.003

  • Liu S, Luo P, Tang M, Hu Q, Polidoro JP, Sun S, Gong Z (2020) Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm 42(2):299–304. https://doi.org/10.1007/s11096-020-01017-0

    Article  PubMed  CAS  Google Scholar 

  • Pharmaceutical Care Research Group UoG (2006) Pharmacotherapy follow-up: the Dader method (3rd revision: 2005). Pharm Pract 4(1):44–53

    Google Scholar 

  • Pharmacist as front-line responders for COVID-19 patient care (2020)

    Google Scholar 

  • Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433. https://doi.org/10.1016/j.jaut.2020.102433

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Song Z, Hu Y, Zheng S, Yang L, Zhao R (2020) Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy: S1551741120303144. https://doi.org/10.1016/j.sapharm.2020.03.027

  • Stevens MP, Patel PK, Nori P (2020) Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck. Infect Control Hosp Epidemiol 41(6):744–745. https://doi.org/10.1017/ice.2020.69

    Article  PubMed  CAS  Google Scholar 

  • Sun X, Li S, Li K, Hu X (2020) Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID-19). Aging Med 3:98–101. https://doi.org/10.1002/agm2.12104

  • Tan S-L, Zhang B-K, Xu P (2020) Chinese pharmacists’ rapid response to the COVID-19 outbreak. American Journal of Health-System Pharmacy:zxaa120. https://doi.org/10.1093/ajhp/zxaa120

  • The Lancet Respiratory Medicine (2020) COVID-19: delay, mitigate, and communicate. Lancet Respir Med 8(4):321. https://doi.org/10.1016/S2213-2600(20)30128-4

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tran BX, Vu GT, Latkin CA, Pham HQ, Phan HT, Le HT, Ho RCM (2020) Characterize health and economic vulnerabilities of workers to control the emergence of COVID-19 in an industrial zone in Vietnam. Saf Sci 129:104811. https://doi.org/10.1016/j.ssci.2020.104811

    Article  PubMed  PubMed Central  Google Scholar 

  • U.S. Department of Health and Human Services (2020) Guidance for licensed pharmacists, COVID-19 testing, and immunity under the PREP Act.

    Google Scholar 

  • Ung COL (2020) Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm 16(4):583–586. https://doi.org/10.1016/j.sapharm.2020.02.003

    Article  Google Scholar 

  • Universidad de Antioquia (2020) Cómo actuamos frente al COVID-19 desde las droguerías

    Google Scholar 

  • World Health Organization (2018) WHO medicines, vaccines and pharmaceutical. WHO

    Google Scholar 

  • World Health Organization (2020) Novel Coronavirus (2019-nCoV). Situation Report – 13

    Google Scholar 

  • Ying W, Qian Y, Kun Z (2020) Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Research in Social and Administrative Pharmacy: S1551741120303259. https://doi.org/10.1016/j.sapharm.2020.04.001

  • Zheng S-Q, Yang L, Zhou P-X, Li H-b, Liu F, Zhao R-S (2020) Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Adm Pharm. https://doi.org/10.1016/j.sapharm.2020.03.012

Download references

Author information

Authors and Affiliations

  1. Research Group on Pharmaceutical Promotion and Prevention, University of Antioquia, Medellín, Colombia

    Pedro Amariles, Mónica Ledezma-Morales, Andrea Salazar-Ospina & Jaime Alejandro Hincapié-García

  2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Medellín, Colombia

    Pedro Amariles, Mónica Ledezma-Morales, Andrea Salazar-Ospina & Jaime Alejandro Hincapié-García

Authors
  1. Pedro Amariles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mónica Ledezma-Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Salazar-Ospina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaime Alejandro Hincapié-García
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Amariles .

Editor information

Editors and Affiliations

  1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Amariles, P., Ledezma-Morales, M., Salazar-Ospina, A., Hincapié-García, J.A. (2021). Pharmacist’s Role and Pharmaceutical Care During the COVID-19 Pandemic. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_33

Download citation

Publish with us

Policies and ethics

Search

Navigation